| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_242942af41160a8ce348401741926daf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0652 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
| filingDate |
2011-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d53e8fbb1a6785e8331e516a42d4a3 |
| publicationDate |
2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011251659-A1 |
| titleOfInvention |
Method of Managing Metabolic Syndrome |
| abstract |
A method is provided for treating metabolic syndrome with the use of a portable, non-invasive light-generating device. A laser beam is directed onto adipose tissue to reduce glucose and triglyceride levels through the activation of adiponectin. The laser beam is directed in accordance with a light regimen that is prescribed by a healthcare provide based one or more measured metabolic syndrome parameters of the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022069755-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10589120-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013178919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014089248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160024308-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130296-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017014640-A1 |
| priorityDate |
2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |